Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Research Alliance: Page 2
PacBio partners with Broad Institute, 10x Genomics to launch single-cell RNA sequencing kit
By
LabPulse.com staff writers
The kit will help single-cell researchers better identify and characterize novel isoforms, novel driver mutations, and cancer fusion genes for research into cancers and neurodegenerative diseases.
October 20, 2022
Broad Institute, Dana-Farber, St. Jude Children's Research Hospital collaborate on pediatric cancers
By
LabPulse.com staff writers
The organizations said they will invest more than $60 million over five years to support a collaboration called the Pediatric Cancer Dependencies Accelerator project.
October 13, 2022
PathAI partners with Roche for AI tech
By
LabPulse.com staff writers
The companies said the partnership allows for broad access to digital pathology diagnostics to support clinical research and companion diagnostic programs globally.
October 14, 2021
MD Anderson, BostonGene enter into strategic alliance
By
LabPulse.com staff writers
The agreement expands upon existing research collaborations between BostonGene and multiple center researchers. MD Anderson and BostonGene will work together on clinical utility studies designed to support incorporating BostonGene testing into national guidelines and adoption as a national standard of care.
September 30, 2021
Pershing Square Foundation funds SARS-CoV-2 research
By
LabPulse.com staff writers
The researchers typically focus on cancer research but are instead using their expertise to better understand SARS-CoV-2, the virus that causes COVID-19. The winning projects include a variety of research topics related to COVID-19 and SARS-CoV-2, including potential treatments, genetic or immune determinants, and testing.
July 7, 2020
Is whole genome sequencing for children with rare diseases worth the price?
By
Leah Sherwood
WGS has been proposed as a possible shortcut out of the "diagnostic odyssey," the ordeal endured by patients with rare diseases as they undergo a seemingly endless series of clinical evaluations, imaging studies, and laboratory tests before obtaining a diagnosis.
June 29, 2020
San Diego research institutes study spread of COVID-19
By
LabPulse.com staff writers
The new collaboration is called the San Diego Epidemiology and Research for COVID Health (SEARCH) alliance. The cross-institutional group is co-led by clinical researchers at Rady Children's Hospital-San Diego, Rady Children's Institute for Genomic Medicine, Scripps Research, and the University of California (UC), San Diego.
June 15, 2020
Taking time out for genetic testing in acute myeloid leukemia may be OK
By
Emily Hayes
The retrospective real-world study evaluated outcomes for AML patients included in the Study Alliance Leukemia (SAL) AML registry, which includes 46 treatment centers in Germany. Researchers set out to evaluate how differences in the length of time from diagnosis to start of treatment correlated with overall survival and other key outcomes in patients newly diagnosed with and previously untreated for AML.
June 4, 2020
Europe raises 7.4B euros for coronavirus response
By
LabPulse.com staff writers
The fundraising event was held in response to a call for more money to respond to COVID-19 by the Global Preparedness Monitoring Board (GPMB), a body convened by the World Health Organization (WHO) and World Bank Group.
May 4, 2020
WHO steps on the gas for collaboration on treatments and tests
By
LabPulse.com staff writers
The organization said that heads of state and global health leaders have committed to accelerating the development and production of new vaccines, tests, and treatments for COVID-19. The entire world is at risk as long as the virus threatens any country, the WHO noted. To date, there have been more than 2.4Â million cases globally and 160,000 deaths.
April 23, 2020
Clinical laboratory market enjoys steady growth, exceeds $121B
By
Bruce Carlson
Clinical laboratories are an essential part of the health industry, Kalorama noted. It is estimated that 70% to 80% of diagnoses by physicians result from laboratory tests, and clinical laboratory services are involved in 100% of patient care plans in oncology indications.Source: Kalorama Information.
February 17, 2020
Gestalt touts tie-ups for cancer image workflow
By
LabPulse.com staff writers
Gestalt markets the PathFlow software platform for managing pathology images in laboratories. MindPeak has a software program for research use only called BreastAI to evaluate breast cancer immunohistochemistry tests. The partners are developing an integrated workflow that allows pathologists to send regions of interest on digital breast cancer images to MindPeak, access AI algorithms quickly, and get annotated results back in real-time. This will result in improved efficiency, with faster turnaround times in labs, according to the companies.
October 6, 2019
Previous Page
Page 2 of 2